BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8703383)

  • 1. Keratinocyte differentiation in acquired cholesteatoma and perforated tympanic membranes.
    Vennix PP; Kuijpers W; Peters TA; Tonnaer EL; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1996 Aug; 122(8):825-32. PubMed ID: 8703383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of cytokeratins in cholesteatomas: evidence of increased migration and proliferation.
    Kim HJ; Tinling SP; Chole RA
    J Korean Med Sci; 2002 Jun; 17(3):381-8. PubMed ID: 12068144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased proliferation and migration of epithelium in advancing experimental cholesteatomas.
    Kim HJ; Tinling SP; Chole RA
    Otol Neurotol; 2002 Nov; 23(6):840-4. PubMed ID: 12438843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does occurrence of keratinizing stratified squamous epithelium in the middle-ear cavity always indicate a cholesteatoma?
    Stenfors LE
    J Laryngol Otol; 2004 Oct; 118(10):757-63. PubMed ID: 15550180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
    Park K; Chun YM; Park HJ; Lee YD
    Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of cytokeratins in retraction pocket cholesteatomas.
    Kim HJ; Tinling SP; Chole RA
    Laryngoscope; 2001 Jun; 111(6):1032-6. PubMed ID: 11404616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of cell proliferation using bromodeoxyuridine labeling and in situ detection of dying cells in the tympanic membrane and middle ear cholesteatoma.
    Koba R; Yagi M; Tabe H; Kawabata I
    Arch Histol Cytol; 1996 Oct; 59(4):339-46. PubMed ID: 8937634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.
    Broekaert D; Cornille A; Eto H; Leigh I; Ramaekers F; Van Muijen G; Coucke P; De Bersaques J; Kluyskens P; Gillis E
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):39-51. PubMed ID: 2453971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
    Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Air-exposed tissue culture of human middle ear epithelium and meatal epidermis: a method to study the advancing front of cholesteatoma.
    Albers-op t' Hof BM; Peek FA; Huisman MA; Grote JJ
    Acta Otolaryngol; 2002 Oct; 122(7):720-5. PubMed ID: 12484648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.
    Holly A; Sittinger M; Bujia J
    Eur Arch Otorhinolaryngol; 1995; 252(6):366-9. PubMed ID: 8679157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of acquired cholesteatoma of the human middle ear: support for the migration hypothesis.
    Karmody CS; Northrop C
    Otol Neurotol; 2012 Jan; 33(1):42-7. PubMed ID: 22143292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesteatoma behind an intact tympanic membrane: histopathologic evidence for a tympanic membrane origin.
    Sudhoff H; Linthicum FH
    Otol Neurotol; 2001 Jul; 22(4):444-6. PubMed ID: 11449096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment.
    Albino AP; Reed JA; Bogdany JK; Sassoon J; Parisier SC
    Am J Otol; 1998 May; 19(3):266-72. PubMed ID: 9596172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of calgranulin A and B in middle ear cholesteatoma].
    Holly A; Bujía J; Lempart K; Serge M
    Laryngorhinootologie; 1995 Jan; 74(1):33-5. PubMed ID: 7888019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.